David Sharp

Company: Microcures

Job title: Chief Executive Officer

Seminars:

Novel siRNA Platform for Cellular-Driven Tissue Repair & Regeneration 9:30 am

Fidgetin-like 2 in cell migration Fidgetin-like 2 as a target for tissue repair Localized siRNA delivery for the treatment of traumatic injury UNPUBLISHED DATARead more

day: Conference Day One